Note from Canaccord this morning on Feb prescriptions
regarding Avanir Pharma (AVNR); Avanir making a move on the news, with 21 million shares short; and the CHMP Vote *next week* on approving Nuedexta in Europe!
March 13, 2013
MONTHLY IMS UPDATE:
NUMBER OF NEUDEXTA PILLS DISPENSED UP 3% IN FEBRUARY WITH 11% GROWTH IN RX
Total Nuedexta prescriptions filled in February were up 11%, with 3% growth in the number of pills dispensed in the same month. Recall that a new Medicare restriction on the number of pills dispensed per prescription (“short cycle dispensing”) has lowered the average number of pills dispensed per prescription, which is inflating Rx numbers relative to the absolute count of pills dispensed per month. Thus, 3% pills-dispensed growth is a better measure of organic growth in Nuedexta demand